Rakuten Medical, Inc.
New Form D on file · 2026-04-13 · the record
Rakuten Medical, Inc. filed a Form D with the Securities and Exchange Commission on 2026-04-13.
Rakuten Medical, Inc. filed a Form D notice of an exempt securities offering with the SEC on April 13, 2026. Rakuten Medical, Inc. was formerly named Rakuten Aspyrian, Inc. The filing reports $111.52M sold. Its industry group is Biotechnology. It names Maeda Minami (Executive Officer), David Chao (Director), Mazen Darwazah (Director) (SEC Form D, April 13, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Rakuten Medical, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-04-13 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Rakuten Medical, Inc.
Free to see. No signup.
More on the people and the money behind Rakuten Medical, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in April 2026, largest first.
Get an email when Rakuten Medical, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Rakuten Medical, Inc. raises, hires or launches. No email unless you switch it on.
Watch Rakuten Medical, Inc. →Get the full cited report on Rakuten Medical, Inc.
What the filing shows about Rakuten Medical, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Rakuten Medical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Rakuten Medical, Inc.'s address as 6885 Flanders Drive, Suite 100, San Diego, CA 92121.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Rakuten Medical, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Rakuten Medical, Inc. is a registered filer with the SEC (CIK 1595215) and has filed since 2022-12-28. 6 filings are on record, the latest on 2026-10-06.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Rakuten Medical, Inc.'s Form D of 2026-04-13 names Maeda Minami, David Chao, Mazen Darwazah and 12 more as its officers, directors or promoters.
Its new offerings report $300.84M sold across 6 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $111.52M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its Alluminox™ technology platform which, in pre-clinical studies have been shown to induce rapid and selective cell killing and tumor necrosis.Rakuten Medical is committed to its mission to conquer cancer and aims to realize a society where cancer patients can lead fulfilling
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Maeda Minami is named as Executive Officer on the Form D that Rakuten Medical, Inc. filed with the SEC on 13 April 2026, one of 15 people that filing names.
David Chao is named as Director on the Form D that Rakuten Medical, Inc. filed with the SEC on 13 April 2026, one of 15 people that filing names.
Mazen Darwazah is named as Director on the Form D that Rakuten Medical, Inc. filed with the SEC on 13 April 2026, one of 15 people that filing names.
Miguel Garcia-Guzman is named as Director on the Form D that Rakuten Medical, Inc. filed with the SEC on 13 April 2026, one of 15 people that filing names.
Kentaro Hyakuno is named as Director on the Form D that Rakuten Medical, Inc. filed with the SEC on 13 April 2026, one of 15 people that filing names.
Hiroshi Mikitani is named as Executive Officer and Director on the Form D that Rakuten Medical, Inc. filed with the SEC on 13 April 2026, one of 15 people that filing names.
Hiroshi Mori is named as Director on the Form D that Rakuten Medical, Inc. filed with the SEC on 13 April 2026, one of 15 people that filing names.
Nitin Nohria is named as Director on the Form D that Rakuten Medical, Inc. filed with the SEC on 13 April 2026, one of 15 people that filing names.
Eiichi Kaga is named as Director on the Form D that Rakuten Medical, Inc. filed with the SEC on 13 April 2026, one of 15 people that filing names.
Tiffany Piecewicz is named as Executive Officer on the Form D that Rakuten Medical, Inc. filed with the SEC on 13 April 2026, one of 15 people that filing names.
Abhijit Bhatia is named as Executive Officer on the Form D that Rakuten Medical, Inc. filed with the SEC on 13 April 2026, one of 15 people that filing names.
Carlos Garcia is named as Executive Officer on the Form D that Rakuten Medical, Inc. filed with the SEC on 13 April 2026, one of 15 people that filing names.
Toshiaki Suzuki is named as Executive Officer on the Form D that Rakuten Medical, Inc. filed with the SEC on 13 April 2026, one of 15 people that filing names.
Hiroyuki Kodama is named as Executive Officer on the Form D that Rakuten Medical, Inc. filed with the SEC on 13 April 2026, one of 15 people that filing names.
Suzane San is named as Executive Officer on the Form D that Rakuten Medical, Inc. filed with the SEC on 13 April 2026, one of 15 people that filing names.
15 people named on the filing — 8 holding an executive role and 7 as directors only.
Named as of the 2026-04-13 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
Of the 15 names on this filing, 12 are drawn here to keep the picture readable. The People tab lists them all.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Rakuten Medical, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Rakuten Medical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Rakuten Medical, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Rakuten Medical, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Rakuten Medical, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (rakuten-med.com).
Each opens in a new tab, filled in for Rakuten Medical, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Diego
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

https://mentionfox.com/funding/rakuten-medical-inc-form-d-26000001